BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 27922973)

  • 1. Incidence and Outcomes of Dermatofibrosarcoma Protuberans in the US Pediatric Population.
    Rubio GA; Alvarado A; Gerth DJ; Tashiro J; Thaller SR
    J Craniofac Surg; 2017 Jan; 28(1):182-184. PubMed ID: 27922973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of dermatofibrosarcoma protuberans in Alberta, Canada, from 1988 to 2007.
    Kuzel P; Metelitsa AI; Dover DC; Salopek TG
    Dermatol Surg; 2012 Sep; 38(9):1461-8. PubMed ID: 22691126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and Survival of Primary Dermatofibrosarcoma Protuberans in the United States.
    Kreicher KL; Kurlander DE; Gittleman HR; Barnholtz-Sloan JS; Bordeaux JS
    Dermatol Surg; 2016 Jan; 42 Suppl 1():S24-31. PubMed ID: 26730971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiological trends and survival outcomes for dermatofibrosarcoma protuberans of the head and neck region.
    Go CC; Lahaie Luna GM; Briceño CA
    Int J Dermatol; 2023 May; 62(5):664-671. PubMed ID: 36318642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results of treatment of advanced dermatofibrosarcoma protuberans (DFSP) with imatinib mesylate - The impact of fibrosarcomatous transformation.
    Rutkowski P; Klimczak A; Ługowska I; Jagielska B; Wągrodzki M; Dębiec-Rychter M; Pieńkowska-Grela B; Świtaj T
    Eur J Surg Oncol; 2017 Jun; 43(6):1134-1141. PubMed ID: 28365129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric dermatofibrosarcoma protuberans in Madrid, Spain: multi-institutional outcomes.
    Valdivielso-Ramos M; Torrelo A; Campos M; Feito M; Gamo R; Rodriguez-Peralto JL
    Pediatr Dermatol; 2014; 31(6):676-82. PubMed ID: 25424208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival in patients with primary dermatofibrosarcoma protuberans: National Cancer Database analysis.
    Trofymenko O; Bordeaux JS; Zeitouni NC
    J Am Acad Dermatol; 2018 Jun; 78(6):1125-1134. PubMed ID: 29175214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Factors, Treatment, and Survival in Dermatofibrosarcoma Protuberans.
    Criscito MC; Martires KJ; Stein JA
    JAMA Dermatol; 2016 Dec; 152(12):1365-1371. PubMed ID: 27262160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dermatofibrosarcoma protuberans: a population-based cancer registry descriptive study of 66 consecutive cases diagnosed between 1982 and 2002.
    Monnier D; Vidal C; Martin L; Danzon A; Pelletier F; Puzenat E; Algros MP; Blanc D; Laurent R; Humbert PH; Aubin F
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1237-42. PubMed ID: 17062038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution.
    DuBay D; Cimmino V; Lowe L; Johnson TM; Sondak VK
    Cancer; 2004 Mar; 100(5):1008-16. PubMed ID: 14983497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of subsequent primary malignancies after dermatofibrosarcoma protuberans diagnosis: a national study.
    Kurlander DE; Martires KJ; Chen Y; Barnholtz-Sloan JS; Bordeaux JS
    J Am Acad Dermatol; 2013 May; 68(5):790-6. PubMed ID: 23261548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermatofibrosarcoma protuberans: the pediatric experience at St. Jude Children's Research Hospital.
    Pappo AS; Rao BN; Cain A; Bodner S; Pratt CB
    Pediatr Hematol Oncol; 1997; 14(6):563-8. PubMed ID: 9383809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dermatofibrosarcoma protuberans in children and adolescents: Clinical presentation, histology, treatment, and review of the literature.
    Tsai YJ; Lin PY; Chew KY; Chiang YC
    J Plast Reconstr Aesthet Surg; 2014 Sep; 67(9):1222-9. PubMed ID: 24973861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermatofibrosarcoma protuberans.
    Dimitropoulos VA
    Dermatol Ther; 2008; 21(6):428-32. PubMed ID: 19076619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective Analysis of a Modern Cohort of Dermatofibrosarcoma Protuberans From 2000 to 2018.
    Baig IT; Lauck K; Nguyen QD
    J Cutan Med Surg; 2023; 27(2):108-116. PubMed ID: 36655601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermatofibrosarcoma protuberans: a clinicopathological study in an African population.
    Mbonde MP; Amir H; Kitinya JN
    East Afr Med J; 1996 Jun; 73(6):410-3. PubMed ID: 8840606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unusual skin tumors: Merkel cell carcinoma, eccrine carcinoma, glomus tumors, and dermatofibrosarcoma protuberans.
    Kampshoff JL; Cogbill TH
    Surg Clin North Am; 2009 Jun; 89(3):727-38. PubMed ID: 19465208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermatofibrosarcoma protuberans: a report on 29 patients treated by Mohs micrographic surgery with long-term follow-up and review of the literature.
    Snow SN; Gordon EM; Larson PO; Bagheri MM; Bentz ML; Sable DB
    Cancer; 2004 Jul; 101(1):28-38. PubMed ID: 15221986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone receptor expression in patients with dermatofibrosarcoma protuberans.
    Kreicher KL; Honda KS; Kurlander DE; Bordeaux JS
    J Am Acad Dermatol; 2016 Dec; 75(6):1205-1209. PubMed ID: 27542587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermatofibrosarcoma protuberans in pediatric patients: a report of 17 cases.
    Posso-De Los Rios CJ; Lara-Corrales I; Ho N
    J Cutan Med Surg; 2014; 18(3):180-5. PubMed ID: 24800706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.